Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
David G. Cox(Université Claude Bernard Lyon 1), Andrew K. Godwin(The University of Melbourne), Manon Ouimet(Centre Hospitalier Universitaire Sainte-Justine), Shani Shimon Paluch(Tel Aviv University), Marie Stenmark Askmalm(Linköping University), Eitan Friedman(University of Pennsylvania), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Daniel Sinnett(Centre Hospitalier Universitaire Sainte-Justine), Margreet G.E.M. Ausems(McGill University Health Centre), Carole Verny-Pierre(Lyon 1 Université), Cora M. Aalfs(University of Amsterdam), Christi J. van Asperen(Loyola University Medical Center), Peter Devilee(Leiden University), Laure Barjhoux(Centre Léon Bérard), Bella Kaufman(NYU Langone Health), Irene L. Andrulis(University of Toronto), Javier Benı́tez(Spanish National Cancer Research Centre), Gisela Barbany Bustinza(Karolinska University Hospital), Csilla I. Szabo(University of Delaware), Jacques Simard(Université Laval), Susan M. Domchek(University City Science Center), Yosr Hamdi(Tunis University), Ute Hamann(German Cancer Research Center), Katherine L. Nathanson(Translational Therapeutics (United States)), Anne‐Marie Gerdes(Copenhagen University Hospital), Matti A. Rookus(The Netherlands Cancer Institute), D. Gareth Evans(Manchester Academic Health Science Centre), Mark H. Greene(Cancer Institute (WIA)), Per Karlsson(University of Gothenburg), Lesley McGuffog(University of Cambridge), Yael Laitman(Sheba Medical Center), Ans M.W. van den Ouweland(Erasmus University Rotterdam), Hans J. J. P. Gille(University of Cambridge), Sue Healey(QIMR Berghofer Medical Research Institute), Åke Borg(Lund University), Timothy R. Rebbeck(University of Pennsylvania), Mads Thomassen(Odense University Hospital), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Penny Soucy(University of Cambridge), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust)
Cited by 43
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k